Contents
Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
December 5, 2019
Black Diamond Therapeutics raises a $85,000,000 series C round from Biotechnology Value Fund, Boxer Capital, Casdin Capital, Deerfield Management Company, Logos Capital and Wellington Managment.
January 2019
Black Diamond Therapeutics raises a $85,000,000 series B round from Invus, New Enterprise Associates, Nextech Invest, Perceptive Advisors, RA Capital Management and Versant Ventures.
Funding Rounds
Open in Query Tool
Patents
Open in Query Tool
Further Resources
Title
Author
Link
Type
Date
References
Company attributes
Industry
Pitchbook URL
Legal Name
Black Diamond Therapeutics, Inc.
Number of Employees (Ranges)
50 – 99
Full Address
One Main Street, 10th Floor Cambridge, MA 02142 United States
25 Health Sciences Drive, Suite 105 Stony Brook, NY 11790 United States
430 E. 29th Street, 11th Floor New York, NY 10016 United States
CIK Number
Place of Incorporation
Investors
Email Address
info@bdtx.com
Phone Number
+16174018444
Total Funding Amount (USD)
170,000,000
Latest Funding Round Date
December 5, 2019
Stock Symbol
BDTX
Exchange
Latest Funding Type
Patents Assigned (Count)
1
Other attributes
Country
Company Operating Status
Active
Ticker Symbol
BDTX
Headquarters
Previous Name
Aset Therapeutics, Inc.
SIC Code
2,836
Latest Funding Round Amount (USD)
85,000,000
